Supha Pharmachem share news, announcements and annual reports
BSE: 539561Commercial Services & SuppliesSmall Cap
SUPHA PHARMACHEM LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 2016
Last close ₹0.25₹0.00 (0.00%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹0.25.
28 Oct: open ₹0.25, high ₹0.25, low ₹0.24
52-week range of traded prices to 28 Oct 2026
₹0.23Low, 22 Oct 2026₹1.66High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr3,473rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 9,96,795
Supha Pharmachem share news and announcements
496 announcements, routine notices left out, newest first. Page 2 of 10.
May 2025
27 May · Board meeting
Meeting on 30 May 2025: audited results5 May · Analysts
5 May · Business
Apr 2025
29 Apr · Analysts
22 Apr · Analysts
17 Apr · Board meeting
Meeting on 24 Apr 2025: rights issue of equity shares16 Apr · Analysts
1 Apr · Board meeting
Meeting on 7 Apr 2025: rights issue
Mar 2025
27 Mar · Meeting
1 Mar · Meeting
Feb 2025
14 Feb · Results
14 Feb · Results
10 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Jan 2025
22 Jan · Reconstitution Of Committees Of The Board
17 Jan · Board meeting
Meeting on 22 Jan 2025: rights issue of equity shares and increase in authorised capital
Dec 2024
23 Dec · Meeting
Nov 2024
14 Nov · Results
14 Nov · Results
11 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results